✦ LIBER ✦

Bortezomib salvage followed by a Phase I/II study of bortezomib plus high-dose melphalan and tandem autologous transplantation for patients with primary resistant myeloma

✍ Scribed by Taiga Nishihori; Todd J. Alekshun; Kenneth Shain; Daniel M. Sullivan; Rachid Baz; Lia Perez; Joseph Pidala; Mohamed A. Kharfan-Dabaja; Jose L. Ochoa-Bayona; Hugo F. Fernandez; Danielle N. Yarde; Vasco Oliveira; William Fulp; Gang Han; Jongphil Kim; Dung-Tsa Chen; Jyoti Raychaudhuri; William Dalton; Claudio Anasetti; Melissa Alsina

Book ID: 114714680
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 217 KB
Volume: 157
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.2012.09099.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bortezomib Followed by a Phase I Study o

Bortezomib Followed by a Phase I Study of Bortezomib in Combination With High-Dose Melphalan as a Preparative Regimen for Hematopoietic Cell Transplants in Patients With Primary Refractory Multiple Myeloma or Plasma Cell Leukemia

✍ T. Nishihori; T.J. Alekshun; D.M. Sullivan; M.A. Kharfan-Dabaja; J. Raychaudhuri 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 86 KB

Sequential vincristine, adriamycin, dexa

Sequential vincristine, adriamycin, dexamethasone (VAD) followed by bortezomib, thalidomide, dexamethasone (VTD) as induction, followed by high-dose therapy with autologous stem cell transplant and consolidation therapy with bortezomib for newly diagnosed multiple myeloma: results of a phase II trial

✍ Hye Jin Kim; Sung-Soo Yoon; Dong Soon Lee; Sang Kyun Sohn; Hyeon Seok Eom; Jung 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 184 KB

184: Phase I Study of Bortezomib, (BTZ)

184: Phase I Study of Bortezomib, (BTZ) followed by High-Dose Melphalan, (HD Mel) and BTZ as Conditioning Regimen for Tandem Peripheral Blood Stem Cell Transplants (TanPSCT) in Patients with Primary Refractory Multiple Myeloma (MM) and Plasma Cell Leukemia (PCL)

✍ M. Alsina; T. Alekshun; C. McIsaac-Simonelli; M. Kharfan-Dabaja; W. Dalton; B. D 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 52 KB

A phase I dose escalation study of high-

A phase I dose escalation study of high-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation (PBSCT) in patients with solid tumors and hematologic malignancies

✍ Demirer, T; lhan, O; Mandel, N M; Arat, M; Günel, N; Çelebi, H; Üstün, C; Akan, 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 70 KB

A phase i/ii study of 166holmium-dotmp i

A phase i/ii study of 166holmium-dotmp in combination with high dose chemotherapy and autologous stem cell transplant(Asct) For the treatment of patients with multiple myeloma(Mm)

✍ W. Bensinger; S. Giralt; J. Eary; D. Podoloff; L. Holmberg; R. Alexanian; M. Goo 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 15 KB

A Novel High Dose Chemotherapy Strategy

A Novel High Dose Chemotherapy Strategy With Bendamustine in Adjunct to Etoposide, Cytarabine and Melphalan (BeEAM) Followed by Autologous Stem Cell Rescue Is Safe and Highly Effective for the Treatment of Resistant/Relapsed Lymphoma Patients: A Phase I-II Study on 44 Patients

✍ G. Visani; L. Malerba; P.M. Stefani; S. Capria; P. Galieni; F. Gaudio; G. Specch 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 61 KB